{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:55:45Z","timestamp":1792007745865,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.metabol.2015.05.002","type":"journal-article","created":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T12:48:29Z","timestamp":1431002909000},"page":"982-990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"64","author":[{"given":"Shobha H.","family":"Ganji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moti L.","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaijinath S.","family":"Kamanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2015.05.002_bb0005","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2015.05.002_bb0010","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.33573","article-title":"Nonalcoholic fatty liver disease","volume":"122","author":"Clark","year":"2002","journal-title":"Gastroenterol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11894-009-0008-4","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk","volume":"11","author":"Misra","year":"2009","journal-title":"Curr Opin Gastroenterol Rep"},{"key":"10.1016\/j.metabol.2015.05.002_bb0020","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two hits?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0025","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1262-3636(07)70061-7","article-title":"Contribution of hepatic de novo lipogenesis and resterification of plasma non esterified fatty acids to plasma triglycerides synthesis during non-alcoholic fatty liver disease","volume":"29","author":"Diraison","year":"2003","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.metabol.2015.05.002_bb0030","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0028-1091981","article-title":"Mechanisms of disease progression in nonalcoholic fatty liver disease","volume":"28","author":"Jou","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.metabol.2015.05.002_bb0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3748\/wjg.14.193","article-title":"Nonalcoholic fatty liver disease and mitochondrial dysfunction","volume":"14","author":"Wei","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/CS20030285","article-title":"Oxidative stress related parameters in the liver of non-alcoholic fatty liver disease patients","volume":"106","author":"Videla","year":"2004","journal-title":"Clin Sci"},{"key":"10.1016\/j.metabol.2015.05.002_bb0045","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/108155890405200822","article-title":"Oxidative stress in non-alcoholic fatty liver disease: pathogenesis and antioxidant therapies","volume":"52","author":"Gawrieh","year":"2004","journal-title":"J Investig Med"},{"key":"10.1016\/j.metabol.2015.05.002_bb0050","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/j.1572-0241.2004.30159.x","article-title":"Systemic levels of lipid peroxidation products and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis","volume":"99","author":"Chalasani","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.hepres.2005.09.020","article-title":"Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases","volume":"33","author":"Seki","year":"2005","journal-title":"Hepatol Res"},{"key":"10.1016\/j.metabol.2015.05.002_bb0060","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/oby.2008.601","article-title":"Liver NF-kappa B and AP-1 DNA binding in obese patients","volume":"17","author":"Videla","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/j.metabol.2015.05.002_bb0065","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jacc.2012.10.030","article-title":"The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression","volume":"61","author":"Lavigne","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0070","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MOL.0b013e3283613a68","article-title":"Recent advances in niacin and lipid metabolism","volume":"24","author":"Kamanna","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.atherosclerosis.2008.04.044","article-title":"Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells","volume":"202","author":"Ganji","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2015.05.002_bb0080","doi-asserted-by":"crossref","first-page":"G320","DOI":"10.1152\/ajpgi.00181.2013","article-title":"Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease","volume":"306","author":"Ganji","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0085","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1194\/jlr.P023614","article-title":"Liver fat reduction with niacin is influenced by DGAT-2 polymorphisms in hypertriglyceridemic patients","volume":"53","author":"Hu","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2015.05.002_bb0090","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/hep.21752","article-title":"Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes","volume":"46","author":"Joshi-Barve","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.05.002_bb0095","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1083\/jcb.100.3.965","article-title":"Nile red: a selective fluorescent stain for intracellular lipid droplets","volume":"100","author":"Greenspan","year":"1985","journal-title":"J Cell Biol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0100","first-page":"H2284","article-title":"Gp91phox contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells","volume":"285","author":"Chamseddine","year":"2003","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cbi.2006.11.004","article-title":"A human hepatocellular in vitro model to investigate steatosis","volume":"165","author":"Gomez-Lechon","year":"2007","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.metabol.2015.05.002_bb0110","first-page":"95","article-title":"Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells","volume":"2","author":"Cui","year":"2010","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.metabol.2015.05.002_bb0115","doi-asserted-by":"crossref","first-page":"29965","DOI":"10.1074\/jbc.M110.128694","article-title":"The effects of palmitate on hepatic insulin resistance are mediated by NADPH oxidase-3-derived reactive oxygen species through JNK and p38MAPK pathways","volume":"285","author":"Gao","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2015.05.002_bb0120","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/109793301753407948","article-title":"Nile red binding to HepG2 cells: an improved assay for in vitro studies of hepatosteatosis","volume":"14","author":"McMillian","year":"2001","journal-title":"In Vitr Mol Toxicol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0125","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1172\/JCI117698","article-title":"Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells","volume":"95","author":"Cui","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2015.05.002_bb0130","doi-asserted-by":"crossref","first-page":"G1287","DOI":"10.1152\/ajpgi.90540.2008","article-title":"Inflammatory NF-kB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production","volume":"296","author":"Tsai","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0135","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1194\/jlr.M007948","article-title":"Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease","volume":"51","author":"Wang","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2015.05.002_bb0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmet.2007.05.005","article-title":"Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver","volume":"6","author":"Monetti","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2015.05.002_bb0145","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.20783","article-title":"Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice","volume":"42","author":"Yu","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.05.002_bb0150","doi-asserted-by":"crossref","first-page":"22678","DOI":"10.1074\/jbc.M704213200","article-title":"Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligo nucleotides reverse diet-induced hepatic steatosis and insulin resistance","volume":"282","author":"Choi","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2015.05.002_bb0155","doi-asserted-by":"crossref","first-page":"e30782","DOI":"10.1371\/journal.pone.0030782","article-title":"Mangiferin decreases plasma free fatty acids through promoting its catabolism in liver by activation of AMPK","volume":"7","author":"Niu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2015.05.002_bb0160","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jhep.2007.12.011","article-title":"Hepatic free fatty acids accumulate in experimental steatohepatitis","volume":"48","author":"Larter","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0165","doi-asserted-by":"crossref","first-page":"21005","DOI":"10.1074\/jbc.M702871200","article-title":"Sequential regulation of diacylglycerol acyltransferase 2 expression by CAAT\/Enhancer-binding protein b (C\/EBPb) and C\/EBPa during adipogenesis","volume":"282","author":"Payne","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2015.05.002_bb0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2337\/db06-0310","article-title":"Mice with a deletion in the gene for CAAT\/Enhancer-binding protein b are protected against diet-induced obesity","volume":"56","author":"Millward","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2015.05.002_bb0175","first-page":"15717","article-title":"CAAT\/Enhancer-binding protein b deletion reduces adiposity, hepatic steatosis, and diabetes in Leprdb\/db mice","volume":"282","author":"Schroeder-Gloeckler","year":"2007","journal-title":"J Biol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0180","doi-asserted-by":"crossref","first-page":"15261","DOI":"10.1074\/jbc.M110827200","article-title":"Protein kinase C-dependent, CAAT\/Enhancer-binding protein b-mediated expression of insulin-like growth factor I gene","volume":"277","author":"Umayahara","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2015.05.002_bb0185","doi-asserted-by":"crossref","first-page":"14364","DOI":"10.1074\/jbc.M111.294157","article-title":"Induction of autophagy by palmitic acid via protein kinase C-mediated signaling pathway independent of mTOR (mammalian target of rapamycin)","volume":"287","author":"Tan","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2015.05.002_bb0190","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/diab.42.6.801","article-title":"Hyperglycemic pseudohypoxia and diabetic complications","volume":"42","author":"Williamson","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2015.05.002_bb0195","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1096\/fj.04-2780fje","article-title":"Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury","volume":"19","author":"Hwang","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2015.05.002_bb0200","first-page":"183","article-title":"In-vitro treatment of HepG2 cells with saturated fatty acids reproduces mitochondrial dysfunction found in nonalcoholic steatohepatitis","volume":"8","author":"Garcia-Ruiz","year":"2015","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.metabol.2015.05.002_bb0205","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1152\/ajpendo.00366.2014","article-title":"CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high fat diet in mice","volume":"308","author":"Chen","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.05.002_bb0210","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/labinvest.2014.98","article-title":"Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes","volume":"94","author":"Choi","year":"2014","journal-title":"Lab Invest"},{"key":"10.1016\/j.metabol.2015.05.002_bb0215","doi-asserted-by":"crossref","first-page":"29965","DOI":"10.1074\/jbc.M110.128694","article-title":"The effects of palmitate on hepatic insulin resistance are mediated by NADPH oxidase-3-derived reactive oxygen species through JNK and p38MAPK pathway","volume":"285","author":"Gao","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2015.05.002_bb0220","doi-asserted-by":"crossref","first-page":"S466","DOI":"10.1097\/01.CCM.0000186783.34908.18","article-title":"Interleukin-8","volume":"33","author":"Remick","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.metabol.2015.05.002_bb0225","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1053\/jhep.2003.50316","article-title":"Cytokines and NASH: a pilot study of the effects of life style modification and vitamin E","volume":"38","author":"Kugelmas","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.05.002_bb0230","first-page":"1549","article-title":"Levels of serum hyaluronic acid, TNF-a and IL-8 in patients with nonalcoholic steatohepatitis","volume":"52","author":"Bahcecioglu","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.metabol.2015.05.002_bb0235","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2353\/ajpath.2009.080999","article-title":"Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis","volume":"175","author":"Rensen","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0240","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.atherosclerosis.2014.05.948","article-title":"Niacin decreases leukocyte myeloperoxidase: mechanistic role of redox agents and src\/p38MAP kinase","volume":"235","author":"Ganji","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2015.05.002_bb0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7861\/clinmedicine.6-1-19","article-title":"Non-alcoholic fatty liver disease: current concepts and management strategies","volume":"6","author":"Day","year":"2006","journal-title":"Clin Med"},{"key":"10.1016\/j.metabol.2015.05.002_bb0250","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.ATV.0000056744.26901.BA","article-title":"Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide","volume":"23","author":"Leopold","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0255","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1096\/fj.00-0893fje","article-title":"Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability","volume":"15","author":"Leopold","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2015.05.002_bb0260","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/0091270007300264","article-title":"Effect of the rate of niacin administration on the plasma and urine pharmacokinetics of niacin and its metabolites","volume":"47","author":"Menon","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0265","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.1994.03510330050033","article-title":"A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients","volume":"271","author":"McKenney","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2015.05.002_bb0270","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1742-1241.2009.02099.x","article-title":"The mechanism and mitigation of niacin-induced flushing","volume":"63","author":"Kamanna","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.metabol.2015.05.002_bb0275","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00041433-200412000-00006","article-title":"Niacin therapy in atherosclerosis","volume":"15","author":"Meyers","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0280","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0026-0495(03)00030-1","article-title":"Nicotinic acid-induced insulin resistance is related to increased circulating fatty acids and fat oxidation but not muscle lipid content","volume":"52","author":"Poynten","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.05.002_bb0285","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jama.284.10.1263","article-title":"Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral artery disease","volume":"284","author":"Elam","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2015.05.002_bb0290","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9149(94)90005-1","article-title":"Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia","volume":"73","author":"Davignon","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2015.05.002_bb0295","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.2146\/ajhp090641","article-title":"Lipid and transaminase concentrations after formulary conversion of Niaspan to Slo-niacin","volume":"67","author":"Byrd","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.metabol.2015.05.002_bb0300","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.amjcard.2004.04.024","article-title":"Safety and compliance with once-daily niacin extended-release\/lovastatin as initial therapy in the Impact of Medical Subspecialty on Patient Compliance to Treatment Study","volume":"94","author":"Rubenfire","year":"2004","journal-title":"Am J Cardiol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515001341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515001341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:08:58Z","timestamp":1758427738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049515001341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0026049515001341"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2015.05.002","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}